- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Halozyme Therapeutics Inc+ Add to Watchlist
HALO:US7.3900 USD 0.0600 0.81%
As of 10:16:40 ET on 05/24/2013.
Company Profile for Halozyme Therapeutics Inc (HALO)
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Halozyme Therapeutics Inc
Key Executives for Halozyme Therapeutics Inc (HALO)
|Gregory Ian Frost "Greg"President/CEO/Co-Founder||David A RamsayChief Financial Officer|
|James P ShafferVP/Chief Commercial Officer||H Michael Shepard "Mike"VP/Chief Scientific Officer|
|Jean I LiuVP/Secretary/General Counsel|